VRS
AEGR

Virginia Retirement Systems’s Aegerion Pharmaceuticals AEGR Stock Holding History

Virginia Retirement Systems’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-19,900
Closed -$664K – 1053
2014
Q3 		$664K Buy
+19,900
New +$618K 0.01% 612
2014
Q2 		– Sell
-6,100
Closed -$282K – 1022
2014
Q1 		$282K Buy
+6,100
New +$358K 0.01% 817
2013
Q3 		– Sell
-8,300
Closed -$526K – 1002
2013
Q2 		$526K Buy
+8,300
New +$441K 0.01% 639

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Virginia Retirement Systems's AEGR Position: Q4 2014 in Review

Virginia Retirement Systems sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 19,900 shares — an estimated $664K sold.

Virginia Retirement Systems first reported a position in AEGR in Q2 2013 and held it in 3 quarters. The position peaked at $664K in Q3 2014. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

  • Virginia Retirement Systems reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Virginia Retirement Systems sold 19,900 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $664K.
  • Virginia Retirement Systems first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Virginia Retirement Systems's Aegerion Pharmaceuticals position peaked at $664K in Q3 2014.
  • 95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on Virginia Retirement Systems's 13F filing for Q4 2014, filed 28 Jan 2015.